KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Shares Issued (2016 - 2025)

Historic Shares Issued for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to $2.8 million.

  • Sarepta Therapeutics' Shares Issued fell 7950.86% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.6 million, marking a year-over-year increase of 112.66%. This contributed to the annual value of $51.2 million for FY2023, which is 7057.55% up from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Shares Issued is $2.8 million, which was down 7950.86% from $13.8 million recorded in Q3 2024.
  • In the past 5 years, Sarepta Therapeutics' Shares Issued registered a high of $39.9 million during Q2 2024, and its lowest value of $339000.0 during Q2 2022.
  • For the 5-year period, Sarepta Therapeutics' Shares Issued averaged around $11.3 million, with its median value being $7.6 million (2021).
  • In the last 5 years, Sarepta Therapeutics' Shares Issued tumbled by 9918.61% in 2021 and then skyrocketed by 162890.86% in 2023.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Shares Issued stood at $2.1 million in 2021, then soared by 426.21% to $11.3 million in 2022, then plummeted by 82.81% to $1.9 million in 2023, then soared by 608.03% to $13.8 million in 2024, then tumbled by 79.51% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $13.8 million for Q3 2024, and $39.9 million during Q2 2024.